Søgning
Søgning på udtrykket 'covid-19' giver 54 resultater
Dokumenter [9] Sider [3] Kalender [1] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [9]
Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Ændringer siden version 29: Indikationer for COVID-19 test er tilføjet.
COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed
Invitation til møde den 20. maj 2022
DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.
Virtuelt årsmøde med fokus på COVID-19 den 7. maj 2021
Afholdt fredag den 25. september 2020 som onlinemøde med fokus på COVID-19
Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale
Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.
Sider [3]
… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Behandling af COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2024v28), Post-COVID-19: Jacob Bodilsen, Christian Brandt, Stine Jo…
…diagnostiske undersøgelser ikke forsinke empirisk behandling ved symptomer herpå. Vaccinationer: Primær vaccination foretages mod Streptococcus pneumoniae, Haemophilus influenzae type B og Neisseria meningitidis. Årlig influenza-vaccination (samt COVID-19 vaccination ud fra aktuelle rekommandationer) anbefales på grund af øget risiko for sekundær bakteriel infektion. Pneumokokker. Den 20-valent konjugerede pneumokok vaccine, PCV20 (Apexxnar), anbefales til voksne. Apexxnar er en…
Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid. Alle infektionsmedicinere bør kende denne publikat…
Kalender [1]
17. januar, Holst Auditoriet, Panum, København
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
BMC Infectious Diseases
15.01.2025
. Abstract. . Background. Low blood absolute lymphocyte count (ALC) may predict severe COVID-19 outcomes. Knowledge gaps remain regarding the relationship of ALC trajectory with clinical outcomes and factors associated with lymphopenia. . . . Methods. Our post hoc analysis of the Therapeutics for Inpatients with COVID-19 platform trial utili…
BMC Infectious Diseases
15.01.2025
. Abstract. . Background. C-reactive protein (CRP) is one of the most commonly monitored inflammatory markers in patients with COVID-19 to gain insight into the inflammation level in the body and to adopt effective disease management and therapeutic strategies. COVID-19 is now less prevalent, and the study of CRP as a biomarker of inflammation still needs deeper understanding, particularly in understanding its role among pat…
Emerg Microbes Infect
14.01.2025
Volume 14, Issue 1, December 2025 .
PLoS One Infectious Diseases
14.01.2025
…he ability of a system to prepare, manage, and learn from shocks. This study investigates the resilience of the German health system by analysing the system-related factors that supported health care workers, a key building block of the system, during the COVID-19 pandemic. We thematically analysed data from 18 semi-structured interviews with key informants from management, policy and academia, 17 in-depth interviews with health care workers, and 10 focus group discussions with health care workers. We ident…
Journal of the American Medical Association
14.01.2025
Receiving COVID-19 and influenza vaccines at the same time should generate a similar reaction as receiving them separately.
Journal of the American Medical Association
14.01.2025
New research suggests SARS-CoV-2 infection may increase the long-term risk of autoimmune or autoinflammatory connective tissue disorders.
Journal of Infectious Diseases
14.01.2025
BMJ Open
12.01.2025
. Objectives. This study aimed to explore the perceptions of donation coordinators in Canada and understand how the COVID-19 pandemic impacted their work activities. . Design. A sequential mixed-method design incorporating a cross-sectional survey investigating demographic data, substance use and abuse and perceived stress related to the pandemic and semistructured qualitative interviews to further investigate those. . Setting. Organ donation organisations across Canada. . Participants. Canadian organ an…
BMC Infectious Diseases
12.01.2025
. Abstract. . Background. Limited information is available regarding the changes in blood culture utilization following the COVID-19 pandemic. Blood culture utilization rate is a critical indicator of diagnostic efficiency for infectious diseases. This study aims to describe the impact of the COVID-19 pandemic on blood culture utilization rate in Shanghai. . . . …
BMC Infectious Diseases
12.01.2025
. Abstract. . Background. Each of the Coronavirus disease 2019 (COVID-19) vaccines has its characteristics that can affect their effectiveness in preventing hospitalization and patient mortality. The present study aimed to determine the effectiveness of COVID-19 vaccines, including whole-virus, protein-based, and vector-based on COVID-19 infection, hospitalization, and mortality. . . …
BMC Infectious Diseases
12.01.2025
…act. . Background. “Hospitels” are hotels that have been specially converted to healthcare facilities. Their utilization emerged as a resource-optimization strategy during the peak of the COVID-19 pandemic in Thailand. This study evaluated the clinical characteristics, outcomes, and admission costs of asymptomatic and mild-to-moderate COVID-19 patients treated in these facilities. . . . …
BMC Infectious Diseases
12.01.2025
. Abstract. . Background. Post-COVID condition (PCC) is characterized by persisting symptoms after the resolution of acute COVID-19. Remdesivir (RDV), a broad-spectrum antiviral drug, has been widely used in patients hospitalized with COVID-19 requiring oxygen therapy. We aimed to evaluate the effects of RDV on PCC by assessing patient-reported and functional outcomes. . . . …
BMC Infectious Diseases
12.01.2025
. Abstract. . Objectives. Our objective was to evaluate the impact of COVID-19 on the proportion of past-year HIV testing in Peru. . . . Methods. Utilizing data from the National Demographic and Health Survey of Peru from 2014 to 2022, we conducted an interrupted time series analysis. The proportion of past-year HIV testing per quarter of ea…
BMJ Open
10.01.2025
. Objectives. COVID-19 vaccine was rolled out for the public in August 2021 in Zamfara state, Northen Nigeria. We determined the factors influencing COVID-19 vaccine acceptance. . Settings. We executed a community-based analytical cross-sectional study during the first 4 months of the second phase of the COVID-19 (Oxford/AstraZeneca) mass vaccination campaign in Zamfara state. . Participants. We used multistage sampling to select 910 household heads. . Outcome measures. We used a semistructured electroni…
BMC Infectious Diseases
10.01.2025
. Abstract. . Background. Limited information is available regarding the changes in blood culture utilization following the COVID-19 pandemic. Blood culture utilization rate is a critical indicator of diagnostic efficiency for infectious diseases. This study aims to describe the impact of the COVID-19 pandemic on blood culture utilization rate in Shanghai. . . . …
BMC Infectious Diseases
10.01.2025
. Abstract. . Background. Each of the Coronavirus disease 2019 (COVID-19) vaccines has its characteristics that can affect their effectiveness in preventing hospitalization and patient mortality. The present study aimed to determine the effectiveness of COVID-19 vaccines, including whole-virus, protein-based, and vector-based on COVID-19 infection, hospitalization, and mortality. . . …
BMC Infectious Diseases
10.01.2025
…act. . Background. “Hospitels” are hotels that have been specially converted to healthcare facilities. Their utilization emerged as a resource-optimization strategy during the peak of the COVID-19 pandemic in Thailand. This study evaluated the clinical characteristics, outcomes, and admission costs of asymptomatic and mild-to-moderate COVID-19 patients treated in these facilities. . . . …
BMC Infectious Diseases
10.01.2025
. Abstract. . Background. Post-COVID condition (PCC) is characterized by persisting symptoms after the resolution of acute COVID-19. Remdesivir (RDV), a broad-spectrum antiviral drug, has been widely used in patients hospitalized with COVID-19 requiring oxygen therapy. We aimed to evaluate the effects of RDV on PCC by assessing patient-reported and functional outcomes. . . . …
PLoS One Infectious Diseases
10.01.2025
by Patrícia Batistella, Luan Marca, Fernanda Castilhos França de Vasconcellos, Eduardo Rodrigues Sanguinet, Augusto Mussi Alvim, Adelar Fochezatto . The impact of COVID-19 has extended beyond the health toll it has taken on populations. The global economy has experienced significant downturns, with unemployment rates reaching unprecedented highs for this century. Nonetheless, the agricultural sector has been uniquely affected by the pandemic, particularly given its crucial role in food supply. This study…
BMJ Open
9.01.2025
. Objectives. This study aims (1) to assess the prevalence of severe fatigue among the general population of Geneva, 2 years into the COVID-19 pandemic and (2) to identify pandemic and non-pandemic factors associated with severe fatigue. . Design. Cross-sectional population-based survey conducted in Spring 2022. . Setting. General adult population of Geneva, Switzerland. . Participants. 6870 adult participants, randomly selected from the general population, included in the Specchio-COVID-19 cohort study,…
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
ProMED
13.01.2025
. . . RESPIRATORY INFECTIONS - ALGERIA: COVID-19 SUBVARIANT, SUSPECTED,. REQUEST FOR INFORMATION. *****************************************************************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Tue 7 Jan 2025 . Source: El-Khabar [in Arabic, trans. Mod.MM, abridged, edited] . bit.ly/4jen7E0 . . . Algerian hospitals emergency departmen…
Morbidity and Mortality Weekly Report (MMWR)
12.01.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
Morbidity and Mortality Weekly Report (MMWR)
11.01.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
Statens Serum Institut
20.12.2024
Covid-19 er på et væsentligt lavere blus end sidste år. Til gengæld er smitten med influenza og RS-virus stigende, og Mycoplasma er også på spil.
Morbidity and Mortality Weekly Report (MMWR)
20.12.2024
This report describes a decrease in reporting of human adenoviruses cases to the National Adenovirus Type Reporting System since the COVID-19 pandemic.
Morbidity and Mortality Weekly Report (MMWR)
13.12.2024
This report describes CDC's recommendation that all people aged ≥65 years and people ages 6 months-64 years with moderate or severe immunocompromise receive a second 2024-2025 COVID-19 vaccine dose 6 months after their last dose.
Eurosurveillance latest updates
13.12.2024
. Background. The COVID-19 pandemic resulted in increased mortality directly and indirectly associated with COVID-19. . . Aim. To assess the impact of the COVID-19 pandemic on all-cause and disease-specific mortality and explore potential health inequalities associated with area-level deprivation in Wales. . . Methods. Two population-based cohort studies were derived from multi-sourced, linked demographic, administrative and electronic health record data from 2016 to 2019 (n = 3,113,319) and 2020 to…
ECDC COVID-19 updates
3.12.2024
This document reports the results of prospective monitoring of COVID-19 vaccine effectiveness.
Statens Serum Institut
22.11.2024
En ny stor nordisk undersøgelse ledet af Statens Serum Institut (SSI) viser, at den opdaterede covid-19-vaccine fra efteråret 2023 effektivt beskytter ældre mod alvorlig sygdom.
Morbidity and Mortality Weekly Report (MMWR)
22.11.2024
This report describes trend categories and nowcasting that provided an early indication of COVID-19 transmissions.
Morbidity and Mortality Weekly Report (MMWR)
22.11.2024
This report describes the percentage of nursing home residents who received a 2024-2025 COVID-19 vaccine, flu vaccines, and influenza vaccine.
Morbidity and Mortality Weekly Report (MMWR)
22.11.2024
This report describes the percentage of eligible adults who received influenza, COVID-19, and RSV vaccines.
Medscape Infectious Diseases
20.11.2024
Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held. . Medscape Medical News
Medscape Infectious Diseases
11.11.2024
COVID-19 infection increased the risk for autoimmune blistering diseases, but vaccination had protective effects, according to the results of a retrospective cohort study. . Medscape Medical News
Eurosurveillance latest updates
8.11.2024
We developed a new activity level setting threshold method, the mean standard deviation (MSD) method to quantify COVID-19 activity levels. This has been validated against the moving epidemic method (MEM), which has been used for influenza for many years, and we observed very similar results. The MSD method can prove to be a tool to use for respiratory viruses with limited historical data or seasonality to quantify activity levels when other respiratory viruses are also circulating. .
Eurosurveillance latest updates
1.11.2024
COVID-19 vaccination recommendations include healthcare workers (HCWs). We measured COVID-19 vaccine effectiveness (CVE) of the autumn 2023 dose against laboratory-confirmed SARS-CoV-2 infection in a prospective cohort study of 1,305 HCWs from 13 European hospitals. Overall CVE was 22% (95% CI: −17 to 48), 49% (95% CI: −8 to 76) before and −11% (95% CI: −84 to 34) after the start of BA.2.86/JN.1 predominant circulation. Autumn 2023 COVID-19 vaccination led to a moderate-to-low redu…
Morbidity and Mortality Weekly Report (MMWR)
1.11.2024
This report describes influenza vaccination and COVID-19 vaccination coverage among health care personnel during the 2023-24 respiratory virus season (October 1, 2023-March 31, 2024).
ECDC COVID-19 updates
29.10.2024
Seasonal influenza and COVID-19 vaccination uptake for risk groups such as the elderly were sub-optimal in several EU/EEA Member States during the 2023-2024 season, according to two reports released today by the European Centre for Disease Prevention and Control (ECDC).
ECDC COVID-19 updates
29.10.2024
This report presents a description of COVID-19 vaccine coverage in the European Union/European Economic Area (EU/EEA) between 1 September 2023 and 31 July 2024.
Eurosurveillance latest updates
26.10.2024
. Background. The first wave of the COVID-19 pandemic in 2020 was largely mitigated by limiting contacts in the general population. In early 2022, most contact-reducing measures were lifted. . . Aim. To assess whether the population has reverted to pre-pandemic contact behaviour and how this would affect transmission potential of a newly emerging pathogen. . . Methods. We compared two studies on contact behaviour in the Netherlands: the PIENTER Corona study, conducted during and after the pandemic (he…